• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION WATCHMAN FLX? PRO; SYSTEM, APPENDAGE CLOSURE, LEFT ATRIAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION WATCHMAN FLX? PRO; SYSTEM, APPENDAGE CLOSURE, LEFT ATRIAL Back to Search Results
Model Number M635WU60400
Medical Device Problem Codes Migration (4003); Failure to Seal (4070)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 03/10/2026
Type of Reportable Event Serious Injury
Event or Problem Description
It was reported that a device leak and implant movement/shift occurred.A left atrial appendage (laa) closure procedure was performed, and a 40mm watchman flx pro closure device was selected to be used on (b)(6) 2026.During the procedure the closure device was implanted with no leaks, passed the tug test, well positioned and sufficient compression.The patient was discharged.During a routine 45-day follow up transesophageal echocardiography (tee), the physician and implanting electrophysiologist noted that the closure device had shifted and a leak developed.No imaging has been retrieved yet and no further information was provided at the time of this report.
 
Additional Manufacturer Narrative
With all the available information, boston scientific (bsc) concludes: device technical analysis: the watchman flx? pro remains implanted; therefore, returned device analysis could not be completed.Device history record review: a review was completed of the device history records (dhr) for the watchman flx? pro, part # m635wu60400 batch # 0037489619.The device was processed through all normal operational conditions and passed all acceptance activities.The dhr review did not identify any deviations or non-conformances that could have contributed to the event.Labeling review: there was no evidence to suggest that the device was used in a manner inconsistent with the labeling.Watchman flx? pro instructions for use (ifu) lists potential complications, risks and adverse events that may be associated with the use of this device which include implant did not seal and implant movement/shift.Risk review: a risk review was completed and confirmed that the events of implant did not seal, and implant movement/shift were defined in the risk documentation.These event types have been accounted for during product risk analysis to support acceptable risk benefit for the product.Investigation conclusion: based on a thorough review of the reported complaint, boston scientific has assigned an investigation conclusion code of known inherent risk of device.
 
Event or Problem Description
It was reported that a device leak and implant movement/shift occurred.A left atrial appendage (laa) closure procedure was performed, and a 40mm watchman flx pro closure device was selected to be used on (b)(6) 2026.During the procedure the closure device was implanted with no leaks, passed the tug test, well positioned and sufficient compression.The patient was discharged.During a routine 45-day follow up transesophageal echocardiography (tee), the physician and implanting electrophysiologist noted that the closure device had shifted and a leak developed.No imaging has been retrieved yet and no further information was provided at the time of this report.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
WATCHMAN FLX? PRO
Common Device Name
SYSTEM, APPENDAGE CLOSURE, LEFT ATRIAL
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
ballybrit business park
galway
EI  
Manufacturer Contact
rachel shields
4100 hamline ave n
arden hills, MN 55112
6512422111
MDR Report Key24674181
Report Number2124215-2026-16013
Device Sequence Number10108804
Product Code NGV
UDI-Device Identifier00191506004637
UDI-Public(01)00191506004637(17)280918(10)37489619
Combination Product (Y/N)N
Initial Reporter StateNY
Initial Reporter CountryUS
PMA/510(K) Number
P130013
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2026
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 04/16/2026
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Model NumberM635WU60400
Device Catalogue NumberM635WU60400
Device Lot Number0037489619
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 03/10/2026
Supplement Date Received by Manufacturer04/13/2026
Initial Report FDA Received Date03/24/2026
Supplement Report FDA Received Date04/16/2026
Date Device Manufactured09/19/2025
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Other;
Patient Age73 YR
Patient SexFemale
-
-